JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
B2305 IWP-L6

Summary: Porcupine inhibitor,highy potent

≥22.45 mg/mL
B5671 JW 67

Summary: inhibitor of canonical Wnt pathway signaling

<39.44 mg/mL
B5679 CCT 031374 hydrobromide

Summary: inhibits TCF-dependent transcription, blocks BIO-induced β-catenin stabilization

<21.72 mg/mL
B4818 WAY-262611

Summary: β-Catenin agonist

insoluble in EtOH; insoluble in H2O; ≥8.95 mg/mL
B4687 iCRT 14

Summary: CRT inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
B7700 IQ 1

Target: Stem Cell Differentiation|PP2A/Nkd interaction

Summary: Maintains embryonic stem cell (ESC) pluripotency

≥37.5 mg/mL
A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL